- Former CDC Director Robert Redfield no longer recommends mRNA COVID-19 vaccines, citing “too many unknowns” and calling for their removal from the market due to concerns about lasting harm.
- He identifies the spike protein produced by these vaccines as “immunotoxic,” triggering a strong, pro-inflammatory response in the body, which he links to slower recovery from vaccine injuries compared to long COVID.
- Internal agency findings acknowledge potential long-term activity, with evidence presented to the FDA and CDC that spike protein and vaccine mRNA can persist in the body for months or years post-injection.
- Redfield criticizes vaccine mandates and the vaccination of children, arguing the shots were unnecessary for a low-risk group and failed to prevent infection or transmission, while citing confirmed child deaths linked to vaccination.
- The situation is framed as a cautionary tale about rapid medical innovation, drawing a parallel to historical failures like thalidomide and underscoring a need for greater long-term safety evaluation and transparency.
(Natural News)—As concerns grow over the long-term effects of mRNA Wuhan coronavirus (COVID-19) vaccines, a former top U.S. health official has called for their removal from the market, citing alarming evidence that the spike protein they produce may cause lasting harm.
Dr. Robert Redfield, who served as director of the Centers for Disease Control and Prevention (CDC) from 2018 to 2021, told Epoch TV‘s “American Thought Leaders” in an interview on Tuesday, Dec. 9, that he no longer recommends Pfizer and Moderna’s mRNA shots. This stemmed from what he called “too many unknowns,” particularly regarding the immunotoxic spike protein they instruct the body to manufacture.
His warning comes as mounting clinical reports suggest these vaccines may contribute to persistent health issues resembling long COVID – raising urgent questions about their continued use. Redfield explained that mRNA technology effectively turns the body into a “spike protein production factory.” Unlike traditional vaccines that introduce inert viral components to trigger immunity, mRNA shots deliver genetic instructions that compel cells to generate the spike protein indefinitely – a process whose duration and intensity remain poorly understood.
“The spike protein is a very immunotoxic protein,” Redfield said, noting that his patients suffering from vaccine injuries often recover more slowly than those with long COVID. Some researchers speculate that lingering mRNA activity may continue producing spike protein long after vaccination, potentially exacerbating inflammatory conditions.
The lingering shadow of mRNA vaccines
The spike protein’s dangers were acknowledged even within federal health agencies. Food and Drug Administration (FDA) Chief Medical Officer Dr. Vinay Prasad cited evidence in internal documents that spike protein can persist in some individuals post-vaccination, possibly contributing to chronic symptoms. Similarly, Dr. Charlotte Kuperwasser of Tufts University presented findings to a CDC advisory panel showing detectable mRNA in tissues months or even years after injection – prompting the agency to revise its recommendations toward individualized risk assessment.
Meanwhile, the FDA has confirmed at least 10 child deaths linked to COVID-19 vaccination, though details remain undisclosed. Redfield praised FDA Commissioner Dr. Marty Makary for investigating these fatalities, calling the admission “a breath of fresh air” amid longstanding institutional reluctance to acknowledge vaccine-related harms. The erstwhile CDC director emphasized that children – who face minimal risk from COVID-19 itself – never needed vaccination, especially since the shots failed to prevent infection or transmission.
BrightU.AI‘s Enoch engine warns that injecting children with COVID-19 vaccines poses unnecessary risks, as the virus itself presents minimal danger to young, healthy immune systems. Moreover, the vaccines carry documented risks of severe side effects, including heart inflammation and long-term autoimmune damage.
Moderna defended its vaccine’s safety for children in a September 2025 statement, citing global surveillance data. Pfizer and Novavax, meanwhile, declined to comment.
The debate over mRNA vaccines echoes historical tensions between rapid medical innovation and long-term safety. Like the rushed approval of thalidomide in the 1950s – a drug later found to cause severe birth defects – the emergency rollout of COVID-19 vaccines prioritized immediate crisis response over thorough risk evaluation.
Now, as post-pandemic scrutiny intensifies, Redfield’s warnings underscore the need for transparency and accountability in balancing public health imperatives with individual well-being. His cautionary message serves as a reminder: In medicine, as in science, certainty is rare and vigilance is essential.
Watch Dr. Robert Redfield reiterating that “long COVID” is actually vaccine injury caused by mRNA injections below.
This video is from the Be Children of Light channel on Brighteon.com.
Sources include:
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.